In the present study, we demonstrate that the levels of IL-17A in serum and tumor samples are significantly increased in TSCC patients and positively correlate with lymph node metastasis and tumor clinical stages of TSCC. Here, IL17A is linked to metastatic malignant neoplasm in the lymph nodes.